BSE Limited has issued a show cause notice to Naturo Indiabull Ltd regarding the compulsory delisting of its securities. The exchange cited the company's failure to revoke trading suspension, which has persisted for more than six months since February 20, 2026.

The notice, dated September 22, 2026, references the company's non-compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Despite earlier communications from the exchange in March 2026 advising the company to rectify these issues, trading remained suspended. Consequently, grounds for delisting were established under Rule 21 of the Securities Contracts (Regulation) Rules read with the Delisting Regulations, 2021.

Naturo Indiabull has been advised to submit a representation within 15 working days explaining why its securities should not be compulsorily delisted. The company may also request a personal hearing before the Delisting Committee. Representations must be submitted via email to the specified address; submissions through other modes will not be considered valid.

Outstanding fines and compliance gaps

The company faces significant financial penalties and procedural hurdles to avoid delisting. As of September 16, 2026, the total outstanding fine payable is ₹27,05,740 (including GST). This amount includes fines levied under SEBI Standard Operating Procedures (SOP) for late or non-submission of various filings, such as quarterly results and shareholding patterns.

Additionally, the company must pay processing fees of ₹2,36,000 and indicative reinstatement fees of ₹5,90,000. The annual listing fees outstanding stand at ₹34,735. Failure to clear these dues and complete mandatory filings will prevent the revocation of suspension.

What the numbers show

The data reveals a critical divergence between the company's capital structure and its operational compliance. While the listed capital matches the issued capital at 18,864,715 shares, the promoter holding stands at 19.609% against a public holding of 80.390% as of June 30, 2026. This high public shareholding amplifies the impact of potential compulsory delisting, as promoters would be liable to acquire shares from public shareholders at a value determined by a valuer within three months of delisting, per Regulation 33 of the Delisting Regulations.

Furthermore, the accumulation of fines totaling over ₹27 lakh relative to the modest annual listing fee of ₹34,735 indicates a prolonged period of regulatory neglect rather than a temporary administrative lapse. The non-submission of results for multiple quarters, including March 2025 and September 2025, underscores a systemic failure in corporate governance that has triggered the exchange's strictest enforcement mechanism.

Naturo Agrotech India Limited reported a net loss of ₹82.08 lakh for the financial year ended March 31, 2026. The company recorded zero revenue from operations, marking a stark contrast to the ₹2.05 crore revenue logged in the previous fiscal year.

The statutory auditor, H. Rajen & Co., issued a qualified opinion on the standalone financial results. The qualification stems from significant non-compliance with Sections 185 and 186 of the Companies Act, 2013, regarding loans and advances, as well as Sections 73 to 76 concerning borrowings from parties other than directors and their relatives.

Financial Performance Overview

The company’s financial position deteriorated further in FY26, with total income collapsing to ₹1 compared to ₹2.06 crore in FY25. Total expenses stood at ₹32.08 lakh, driven primarily by depreciation and amortization charges of ₹45.30 lakh. Employee benefit expenses decreased to ₹9.77 lakh from ₹34.37 lakh in the prior year.

Audit Qualifications and Compliance Issues

The auditor highlighted that loans and advances totaling ₹54.58 crore were granted to various parties in contravention of statutory provisions. No board resolutions or shareholder approvals were provided for these transactions, leaving the recoverability of these balances uncertain. Additionally, the company accepted borrowings of ₹8.04 crore from non-director entities without adhering to regulatory requirements, and failed to provide counter-party ledger confirmations.

Inventory valuation also raised concerns. The closing stock stood at ₹10.65 crore, but the auditor noted uncertainty regarding its existence and fair valuation due to the absence of a physical verification report. The management valued inventory only at cost, which is non-compliant with Ind AS 2 requiring valuation at the lower of cost or net realizable value.

Statutory Dues and Receivables

Significant overdue statutory liabilities were disclosed, including an outstanding income tax liability of ₹1.27 crore and unpaid TDS/TCS dues of ₹10.89 lakh. The auditor noted that while tax payments were made as per returns filed with the Income Tax department, corresponding entries were not recorded in the books of accounts for the past three years.

Trade receivables amounted to ₹14.84 crore as of March 31, 2026. The auditor was unable to verify these balances due to the lack of direct confirmation from debtors. Furthermore, the company did not maintain accounting software with an enabled edit log feature, limiting the ability to independently verify changes to financial records as required under Rule 3(1) of the Companies (Accounts) Rules, 2014.

What the Numbers Show

A critical divergence exists between the company’s asset base and its liquidity. While total assets remain substantial at ₹81.60 crore, cash and cash equivalents have dwindled to just ₹59,225. This extreme liquidity constraint is juxtaposed against short-term borrowings of ₹7.02 crore and trade payables of ₹25.44 crore, indicating severe pressure on near-term obligations. The concentration of assets in unverified loans and advances (₹54.58 crore) and inventory (₹10.65 crore) suggests that the balance sheet’s health is heavily dependent on assets whose existence and recoverability the auditor could not confirm.